https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-and-Allergan-Announce-Supplemental-New-Drug-Application-for-72-mcg-Linaclotide-in-Chronic-Idiopathic-Constipation-Has-Been-Accepted-for-FDA-Review/default.aspx
https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-and-Allergan-Announce-Supplemental-New-Drug-Application-for-72-mcg-Linaclotide-in-Chronic-Idiopathic-Constipation-Has-Been-Accepted-for-FDA-Review/default.aspx